Skip to main content
 

Fixed Phage agrees to strategic collaboration in the animal health space

British biotechnology company Fixed Phage, which has been working with the Rapid Innovation AgriFood and Industrial Biotech teams since November 2019, has agreed a collaboration with Carus Animal Health to commercialise their patented technology in dealing with companion animal diseases.

The focus of the new arrangement will be the use of Fixed Phage technology which provides the opportunity to deploy bacteriophages, natural anti-bacterials in stable, commercially-relevant formulations. Bacteriophages normally lack stability and robustness when used for therapeutic interventions, however the Fixed Phage technology provides robust delivery and efficacy.

Full details of the collaboration can be found in the press release here